Position in TRVI
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$6,022,693
+$1,964,060 QoQ
Shares Held
504,836
+55.7% QoQ
Ownership
0.356%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
8 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 97.90129863955819.ToString("F0")%
None 2.098701360441807.ToString("F0")%
Common Shares in TRVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026AMERIPRISE FINANCIAL INC holds $4,230,069,783 across 189 Biotechnology names. TRVI ranks #66 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,633,481 | $1,175,954,602 | |
| 2 | INSM |
INSMED Inc
|
3,057,718 | $499,998,043 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,608,476 | $304,082,386 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
319,677 | $246,995,233 | |
| 5 | ARGX |
Argenx SE
|
215,910 | $157,668,275 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
1,579,793 | $153,634,868 | |
| 7 | ASND |
Ascendis Pharma A/S
|
476,466 | $108,982,067 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,248,521 | $92,715,166 |
All Filings in TRVI
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,022,693 | 504,836 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $4,058,633 | 324,172 | Shares | Defined | 2026-02-17 | |
| 2025-06-30 | $847,051 | 154,854 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $741,980 | 117,962 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $398,750 | 96,784 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $112,614 | 33,717 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $44,545 | 14,948 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $74,547 | 21,608 | Shares | Defined | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||